Vivesto AB (OASMY)
0.02
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Vivesto Max Drawdown (5Y): 99.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.99% |
| March 31, 2024 | 99.99% |
| February 29, 2024 | 99.99% |
| January 31, 2024 | 99.99% |
| December 31, 2023 | 99.99% |
| November 30, 2023 | 99.99% |
| October 31, 2023 | 99.99% |
| September 30, 2023 | 99.99% |
| August 31, 2023 | 99.99% |
| July 31, 2023 | 99.99% |
| June 30, 2023 | 99.99% |
| May 31, 2023 | 99.99% |
| April 30, 2023 | 99.74% |
| March 31, 2023 | 99.74% |
| February 28, 2023 | 99.74% |
| January 31, 2023 | 99.74% |
| December 31, 2022 | 99.74% |
| November 30, 2022 | 99.74% |
| October 31, 2022 | 99.74% |
| September 30, 2022 | 97.40% |
| August 31, 2022 | 97.40% |
| July 31, 2022 | 94.88% |
| June 30, 2022 | 94.88% |
| May 31, 2022 | 94.88% |
| April 30, 2022 | 88.82% |
| Date | Value |
|---|---|
| March 31, 2022 | 88.64% |
| February 28, 2022 | 86.84% |
| January 31, 2022 | 86.84% |
| December 31, 2021 | 84.51% |
| November 30, 2021 | 84.51% |
| October 31, 2021 | 84.51% |
| September 30, 2021 | 84.51% |
| August 31, 2021 | 84.51% |
| July 31, 2021 | 84.51% |
| June 30, 2021 | 84.51% |
| May 31, 2021 | 84.51% |
| April 30, 2021 | 84.51% |
| March 31, 2021 | 84.51% |
| February 28, 2021 | 84.51% |
| January 31, 2021 | 84.51% |
| December 31, 2020 | 84.51% |
| November 30, 2020 | 84.51% |
| October 31, 2020 | 84.51% |
| September 30, 2020 | 84.51% |
| August 31, 2020 | 84.51% |
| July 31, 2020 | 84.51% |
| June 30, 2020 | 84.51% |
| May 31, 2020 | 84.51% |
| April 30, 2020 | 84.51% |
| March 31, 2020 | 84.51% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
83.55%
Minimum
May 2019
99.99%
Maximum
Jun 2023
90.44%
Average
84.51%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
| Abliva AB | 99.34% |
| Karolinska Development AB | -- |
| Calliditas Therapeutics AB | -- |
| Oncopeptides AB | -- |
| Olink Holding AB | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -300.90 |
| Beta (5Y) | 21.72 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 4.59K% |
| Historical Sharpe Ratio (5Y) | -0.0128 |
| Historical Sortino (5Y) | -0.7358 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 51.22% |